Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Astellas Pharma Inc. (ALPMY) had Debt to Capital Ratio of 0.27 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$3.49B |
|
$472.11M |
|
$654.32M |
|
$2.84B |
|
$2.72B |
|
$770.11M |
|
$-146.23M |
|
$623.87M |
|
$623.87M |
|
$472.11M |
|
$472.11M |
|
$472.11M |
|
$472.11M |
|
$770.11M |
|
$1.10B |
|
1.79B |
|
1.80B |
|
$0.26 |
|
$0.26 |
|
| Balance Sheet Financials | |
$8.92B |
|
$2.23B |
|
$14.09B |
|
$23.02B |
|
$7.64B |
|
$3.85B |
|
$5.15B |
|
$12.79B |
|
$10.22B |
|
$293.95M |
|
$10.22B |
|
-- |
|
| Cash Flow Statement Financials | |
$378.38M |
|
$-115.54M |
|
$-76.19M |
|
$1.30B |
|
$1.49B |
|
$186.49M |
|
-- |
|
$-457.06M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.17 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.27 |
0.62 |
|
81.25% |
|
22.07% |
|
22.07% |
|
-- |
|
17.88% |
|
13.53% |
|
$290.00M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.31 |
|
0.74 |
|
121.19 |
|
4.62% |
|
160.61% |
|
2.05% |
|
3.35% |
|
-- |
|
$0.16 |
|
$0.21 |
|